nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.24	0.406	CbGbCtD
Tolmetin—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.182	0.308	CbGbCtD
Tolmetin—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0955	0.162	CbGbCtD
Tolmetin—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0739	0.125	CbGbCtD
Tolmetin—MPO—saliva—acquired immunodeficiency syndrome	0.00952	0.106	CbGeAlD
Tolmetin—MPO—endothelium—acquired immunodeficiency syndrome	0.00467	0.0519	CbGeAlD
Tolmetin—MPO—blood plasma—acquired immunodeficiency syndrome	0.00414	0.0461	CbGeAlD
Tolmetin—TDO2—lung—acquired immunodeficiency syndrome	0.00413	0.046	CbGeAlD
Tolmetin—TDO2—nervous system—acquired immunodeficiency syndrome	0.00383	0.0426	CbGeAlD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CCL3L1—acquired immunodeficiency syndrome	0.00369	0.0399	CbGpPWpGaD
Tolmetin—TDO2—central nervous system—acquired immunodeficiency syndrome	0.00369	0.041	CbGeAlD
Tolmetin—TDO2—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00321	0.0347	CbGpPWpGaD
Tolmetin—TDO2—brain—acquired immunodeficiency syndrome	0.00293	0.0326	CbGeAlD
Tolmetin—TDO2—lymph node—acquired immunodeficiency syndrome	0.00283	0.0315	CbGeAlD
Tolmetin—CXCL8—blood—acquired immunodeficiency syndrome	0.0026	0.0289	CbGeAlD
Tolmetin—CXCL8—bone marrow—acquired immunodeficiency syndrome	0.00251	0.028	CbGeAlD
Tolmetin—CXCL8—spinal cord—acquired immunodeficiency syndrome	0.0025	0.0278	CbGeAlD
Tolmetin—CXCL8—vagina—acquired immunodeficiency syndrome	0.00241	0.0268	CbGeAlD
Tolmetin—CXCL8—lung—acquired immunodeficiency syndrome	0.00228	0.0253	CbGeAlD
Tolmetin—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00221	0.0246	CbGeAlD
Tolmetin—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00212	0.0235	CbGeAlD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CCL4—acquired immunodeficiency syndrome	0.00202	0.0219	CbGpPWpGaD
Tolmetin—MPO—skin of body—acquired immunodeficiency syndrome	0.00199	0.0222	CbGeAlD
Tolmetin—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00197	0.0219	CbGeAlD
Tolmetin—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00188	0.0209	CbGeAlD
Tolmetin—CXCL8—EBV LMP1 signaling—CCL5—acquired immunodeficiency syndrome	0.00182	0.0197	CbGpPWpGaD
Tolmetin—MPO—lymphoid tissue—acquired immunodeficiency syndrome	0.00161	0.018	CbGeAlD
Tolmetin—CXCL8—brain—acquired immunodeficiency syndrome	0.00161	0.0179	CbGeAlD
Tolmetin—MPO—digestive system—acquired immunodeficiency syndrome	0.00159	0.0177	CbGeAlD
Tolmetin—CXCL8—lymph node—acquired immunodeficiency syndrome	0.00156	0.0173	CbGeAlD
Tolmetin—MPO—blood—acquired immunodeficiency syndrome	0.00152	0.0169	CbGeAlD
Tolmetin—MPO—bone marrow—acquired immunodeficiency syndrome	0.00147	0.0163	CbGeAlD
Tolmetin—MPO—spinal cord—acquired immunodeficiency syndrome	0.00146	0.0163	CbGeAlD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00139	0.015	CbGpPWpGaD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CCL3—acquired immunodeficiency syndrome	0.00138	0.0149	CbGpPWpGaD
Tolmetin—TDO2—Monoamine Transport—TNF—acquired immunodeficiency syndrome	0.00136	0.0147	CbGpPWpGaD
Tolmetin—MPO—lung—acquired immunodeficiency syndrome	0.00133	0.0148	CbGeAlD
Tolmetin—MPO—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.0013	0.0141	CbGpPWpGaD
Tolmetin—SLC22A6—brain—acquired immunodeficiency syndrome	0.00126	0.014	CbGeAlD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—CSF2—acquired immunodeficiency syndrome	0.00125	0.0136	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—CCL4—acquired immunodeficiency syndrome	0.00125	0.0135	CbGpPWpGaD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CCR2—acquired immunodeficiency syndrome	0.00125	0.0135	CbGpPWpGaD
Tolmetin—MPO—nervous system—acquired immunodeficiency syndrome	0.00123	0.0137	CbGeAlD
Tolmetin—MPO—central nervous system—acquired immunodeficiency syndrome	0.00119	0.0132	CbGeAlD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CXCR4—acquired immunodeficiency syndrome	0.00118	0.0127	CbGpPWpGaD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CXCL12—acquired immunodeficiency syndrome	0.00118	0.0127	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.00102	0.0111	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.000984	0.0106	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CCL4—acquired immunodeficiency syndrome	0.000978	0.0106	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	0.000975	0.0105	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	0.000964	0.0104	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.00095	0.0103	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	0.000949	0.0103	CbGpPWpGaD
Tolmetin—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000945	0.0105	CbGeAlD
Tolmetin—MPO—brain—acquired immunodeficiency syndrome	0.000942	0.0105	CbGeAlD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000932	0.0101	CbGpPWpGaD
Tolmetin—MPO—lymph node—acquired immunodeficiency syndrome	0.00091	0.0101	CbGeAlD
Tolmetin—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000903	0.0101	CbGeAlD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CCL5—acquired immunodeficiency syndrome	0.000894	0.00967	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	0.000893	0.00965	CbGpPWpGaD
Tolmetin—Renal failure—Indinavir—acquired immunodeficiency syndrome	0.000892	0.00394	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Ritonavir—acquired immunodeficiency syndrome	0.000887	0.00391	CcSEcCtD
Tolmetin—Urinary tract infection—Indinavir—acquired immunodeficiency syndrome	0.000882	0.00389	CcSEcCtD
Tolmetin—Hepatitis—Zidovudine—acquired immunodeficiency syndrome	0.000876	0.00387	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000874	0.00945	CbGpPWpGaD
Tolmetin—Gastritis—Ritonavir—acquired immunodeficiency syndrome	0.000871	0.00384	CcSEcCtD
Tolmetin—Flatulence—Nelfinavir—acquired immunodeficiency syndrome	0.000867	0.00383	CcSEcCtD
Tolmetin—Haematuria—Indinavir—acquired immunodeficiency syndrome	0.000865	0.00382	CcSEcCtD
Tolmetin—Flatulence—Stavudine—acquired immunodeficiency syndrome	0.000865	0.00382	CcSEcCtD
Tolmetin—Drowsiness—Efavirenz—acquired immunodeficiency syndrome	0.000858	0.00378	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—CCL3—acquired immunodeficiency syndrome	0.000856	0.00925	CbGpPWpGaD
Tolmetin—Renal failure—Efavirenz—acquired immunodeficiency syndrome	0.000843	0.00372	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000842	0.00911	CbGpPWpGaD
Tolmetin—Gastritis—Saquinavir—acquired immunodeficiency syndrome	0.000839	0.0037	CcSEcCtD
Tolmetin—Weight increased—Delavirdine—acquired immunodeficiency syndrome	0.000837	0.0037	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CCL3—acquired immunodeficiency syndrome	0.000836	0.00904	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.000834	0.00902	CbGpPWpGaD
Tolmetin—Erythema multiforme—Zidovudine—acquired immunodeficiency syndrome	0.000828	0.00366	CcSEcCtD
Tolmetin—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.000825	0.00364	CcSEcCtD
Tolmetin—Haematuria—Efavirenz—acquired immunodeficiency syndrome	0.000818	0.00361	CcSEcCtD
Tolmetin—Hepatitis—Indinavir—acquired immunodeficiency syndrome	0.000815	0.0036	CcSEcCtD
Tolmetin—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.000808	0.00356	CcSEcCtD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CCR5—acquired immunodeficiency syndrome	0.000806	0.00871	CbGpPWpGaD
Tolmetin—CXCL8—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000805	0.0087	CbGpPWpGaD
Tolmetin—Stomatitis—Delavirdine—acquired immunodeficiency syndrome	0.0008	0.00353	CcSEcCtD
Tolmetin—Urinary tract infection—Delavirdine—acquired immunodeficiency syndrome	0.000798	0.00352	CcSEcCtD
Tolmetin—Dysuria—Ritonavir—acquired immunodeficiency syndrome	0.000796	0.00351	CcSEcCtD
Tolmetin—Abdominal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000785	0.00346	CcSEcCtD
Tolmetin—Haematuria—Delavirdine—acquired immunodeficiency syndrome	0.000782	0.00345	CcSEcCtD
Tolmetin—Epistaxis—Delavirdine—acquired immunodeficiency syndrome	0.000774	0.00341	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—MBL2—acquired immunodeficiency syndrome	0.00077	0.00833	CbGpPWpGaD
Tolmetin—Erythema multiforme—Indinavir—acquired immunodeficiency syndrome	0.00077	0.0034	CcSEcCtD
Tolmetin—Weight decreased—Ritonavir—acquired immunodeficiency syndrome	0.00077	0.0034	CcSEcCtD
Tolmetin—Hepatitis—Efavirenz—acquired immunodeficiency syndrome	0.00077	0.0034	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000762	0.00823	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000761	0.00823	CbGpPWpGaD
Tolmetin—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000756	0.00841	CbGeAlD
Tolmetin—Flatulence—Zidovudine—acquired immunodeficiency syndrome	0.000752	0.00332	CcSEcCtD
Tolmetin—Abdominal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000749	0.00331	CcSEcCtD
Tolmetin—Renal failure—Ritonavir—acquired immunodeficiency syndrome	0.000746	0.00329	CcSEcCtD
Tolmetin—Weight increased—Saquinavir—acquired immunodeficiency syndrome	0.000745	0.00329	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	0.000745	0.00806	CbGpPWpGaD
Tolmetin—Visual impairment—Efavirenz—acquired immunodeficiency syndrome	0.000742	0.00327	CcSEcCtD
Tolmetin—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.000742	0.00327	CcSEcCtD
Tolmetin—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.000742	0.00327	CcSEcCtD
Tolmetin—Weight decreased—Saquinavir—acquired immunodeficiency syndrome	0.000741	0.00327	CcSEcCtD
Tolmetin—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00074	0.00326	CcSEcCtD
Tolmetin—Stomatitis—Ritonavir—acquired immunodeficiency syndrome	0.00074	0.00326	CcSEcCtD
Tolmetin—Urinary tract infection—Ritonavir—acquired immunodeficiency syndrome	0.000738	0.00325	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	0.000737	0.00797	CbGpPWpGaD
Tolmetin—Hepatitis—Delavirdine—acquired immunodeficiency syndrome	0.000737	0.00325	CcSEcCtD
Tolmetin—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000732	0.00814	CbGeAlD
Tolmetin—Dysuria—Lamivudine—acquired immunodeficiency syndrome	0.000731	0.00322	CcSEcCtD
Tolmetin—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.000728	0.00321	CcSEcCtD
Tolmetin—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000726	0.0032	CcSEcCtD
Tolmetin—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.000726	0.0032	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	0.000725	0.00784	CbGpPWpGaD
Tolmetin—Haematuria—Ritonavir—acquired immunodeficiency syndrome	0.000723	0.00319	CcSEcCtD
Tolmetin—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000723	0.00804	CbGeAlD
Tolmetin—PTGS1—blood—acquired immunodeficiency syndrome	0.00072	0.00801	CbGeAlD
Tolmetin—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.000718	0.00317	CcSEcCtD
Tolmetin—Renal failure—Saquinavir—acquired immunodeficiency syndrome	0.000718	0.00317	CcSEcCtD
Tolmetin—Tinnitus—Efavirenz—acquired immunodeficiency syndrome	0.000718	0.00317	CcSEcCtD
Tolmetin—Epistaxis—Ritonavir—acquired immunodeficiency syndrome	0.000716	0.00316	CcSEcCtD
Tolmetin—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.000715	0.00316	CcSEcCtD
Tolmetin—Stomatitis—Saquinavir—acquired immunodeficiency syndrome	0.000712	0.00314	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00071	0.00768	CbGpPWpGaD
Tolmetin—Urinary tract infection—Saquinavir—acquired immunodeficiency syndrome	0.00071	0.00313	CcSEcCtD
Tolmetin—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.000705	0.00311	CcSEcCtD
Tolmetin—Oedema—Abacavir—acquired immunodeficiency syndrome	0.000705	0.00311	CcSEcCtD
Tolmetin—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000703	0.0031	CcSEcCtD
Tolmetin—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000701	0.00309	CcSEcCtD
Tolmetin—Flatulence—Indinavir—acquired immunodeficiency syndrome	0.000699	0.00308	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IFNA1—acquired immunodeficiency syndrome	0.000697	0.00753	CbGpPWpGaD
Tolmetin—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.000696	0.00307	CcSEcCtD
Tolmetin—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000694	0.00772	CbGeAlD
Tolmetin—CXCL8—EBV LMP1 signaling—TNF—acquired immunodeficiency syndrome	0.000691	0.00747	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000691	0.00305	CcSEcCtD
Tolmetin—Epistaxis—Saquinavir—acquired immunodeficiency syndrome	0.000689	0.00304	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000689	0.00745	CbGpPWpGaD
Tolmetin—PTGS2—blood—acquired immunodeficiency syndrome	0.000688	0.00766	CbGeAlD
Tolmetin—Tinnitus—Delavirdine—acquired immunodeficiency syndrome	0.000687	0.00303	CcSEcCtD
Tolmetin—Renal failure—Lamivudine—acquired immunodeficiency syndrome	0.000685	0.00302	CcSEcCtD
Tolmetin—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.000681	0.00301	CcSEcCtD
Tolmetin—Stomatitis—Lamivudine—acquired immunodeficiency syndrome	0.000679	0.003	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.000679	0.00734	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	0.000676	0.00731	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL10—acquired immunodeficiency syndrome	0.000676	0.00731	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000675	0.00298	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CCL3—acquired immunodeficiency syndrome	0.000668	0.00722	CbGpPWpGaD
Tolmetin—PTGS1—vagina—acquired immunodeficiency syndrome	0.000668	0.00743	CbGeAlD
Tolmetin—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000666	0.00741	CbGeAlD
Tolmetin—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000663	0.00738	CbGeAlD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—acquired immunodeficiency syndrome	0.000661	0.00714	CbGpPWpGaD
Tolmetin—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.00066	0.00291	CcSEcCtD
Tolmetin—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000659	0.00291	CcSEcCtD
Tolmetin—CXCL8—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000659	0.00713	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL4—acquired immunodeficiency syndrome	0.000658	0.00712	CbGpPWpGaD
Tolmetin—Epistaxis—Lamivudine—acquired immunodeficiency syndrome	0.000657	0.0029	CcSEcCtD
Tolmetin—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.000656	0.0029	CcSEcCtD
Tolmetin—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.000656	0.00289	CcSEcCtD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—acquired immunodeficiency syndrome	0.000653	0.00706	CbGpPWpGaD
Tolmetin—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000652	0.00288	CcSEcCtD
Tolmetin—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000652	0.00288	CcSEcCtD
Tolmetin—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.00065	0.00287	CcSEcCtD
Tolmetin—CXCL8—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.00065	0.00702	CbGpPWpGaD
Tolmetin—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.000649	0.00286	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	0.000649	0.00702	CbGpPWpGaD
Tolmetin—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000649	0.00286	CcSEcCtD
Tolmetin—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000644	0.00284	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	0.000643	0.00696	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—acquired immunodeficiency syndrome	0.000643	0.00695	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	0.000639	0.00691	CbGpPWpGaD
Tolmetin—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000639	0.00282	CcSEcCtD
Tolmetin—PTGS2—vagina—acquired immunodeficiency syndrome	0.000638	0.0071	CbGeAlD
Tolmetin—MPO—IL23-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.000637	0.00689	CbGpPWpGaD
Tolmetin—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000637	0.00281	CcSEcCtD
Tolmetin—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.000635	0.0028	CcSEcCtD
Tolmetin—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000632	0.00279	CcSEcCtD
Tolmetin—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.000632	0.00279	CcSEcCtD
Tolmetin—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.000632	0.00279	CcSEcCtD
Tolmetin—PTGS1—lung—acquired immunodeficiency syndrome	0.000631	0.00703	CbGeAlD
Tolmetin—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.00063	0.00278	CcSEcCtD
Tolmetin—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000625	0.00276	CcSEcCtD
Tolmetin—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.000622	0.00275	CcSEcCtD
Tolmetin—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000622	0.00275	CcSEcCtD
Tolmetin—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.00062	0.00274	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000619	0.0067	CbGpPWpGaD
Tolmetin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000619	0.00273	CcSEcCtD
Tolmetin—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000612	0.0027	CcSEcCtD
Tolmetin—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000611	0.0027	CcSEcCtD
Tolmetin—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000609	0.00269	CcSEcCtD
Tolmetin—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000607	0.00268	CcSEcCtD
Tolmetin—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000604	0.00266	CcSEcCtD
Tolmetin—PTGS2—lung—acquired immunodeficiency syndrome	0.000604	0.00672	CbGeAlD
Tolmetin—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000592	0.00261	CcSEcCtD
Tolmetin—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000591	0.00261	CcSEcCtD
Tolmetin—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000589	0.0026	CcSEcCtD
Tolmetin—TDO2—Metabolism—TAT—acquired immunodeficiency syndrome	0.000589	0.00637	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000587	0.00259	CcSEcCtD
Tolmetin—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000586	0.00259	CcSEcCtD
Tolmetin—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000586	0.00259	CcSEcCtD
Tolmetin—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000586	0.00258	CcSEcCtD
Tolmetin—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000585	0.00651	CbGeAlD
Tolmetin—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000584	0.00258	CcSEcCtD
Tolmetin—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000579	0.00255	CcSEcCtD
Tolmetin—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000579	0.00255	CcSEcCtD
Tolmetin—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000577	0.00255	CcSEcCtD
Tolmetin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000575	0.00254	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.000574	0.0062	CbGpPWpGaD
Tolmetin—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000571	0.00252	CcSEcCtD
Tolmetin—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000571	0.00252	CcSEcCtD
Tolmetin—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000569	0.00251	CcSEcCtD
Tolmetin—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000568	0.00251	CcSEcCtD
Tolmetin—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000568	0.00251	CcSEcCtD
Tolmetin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000567	0.0025	CcSEcCtD
Tolmetin—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000567	0.0025	CcSEcCtD
Tolmetin—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000566	0.0025	CcSEcCtD
Tolmetin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000566	0.0025	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000565	0.00611	CbGpPWpGaD
Tolmetin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000564	0.00249	CcSEcCtD
Tolmetin—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000563	0.00626	CbGeAlD
Tolmetin—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000562	0.00248	CcSEcCtD
Tolmetin—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00056	0.00247	CcSEcCtD
Tolmetin—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000559	0.00622	CbGeAlD
Tolmetin—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000558	0.00246	CcSEcCtD
Tolmetin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000558	0.00246	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000554	0.00599	CbGpPWpGaD
Tolmetin—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000553	0.00244	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.00055	0.00595	CbGpPWpGaD
Tolmetin—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000548	0.00242	CcSEcCtD
Tolmetin—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000546	0.00241	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.000544	0.00588	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000539	0.00583	CbGpPWpGaD
Tolmetin—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000538	0.00599	CbGeAlD
Tolmetin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000537	0.00237	CcSEcCtD
Tolmetin—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000536	0.00237	CcSEcCtD
Tolmetin—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000536	0.00236	CcSEcCtD
Tolmetin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000532	0.00235	CcSEcCtD
Tolmetin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000532	0.00235	CcSEcCtD
Tolmetin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000524	0.00231	CcSEcCtD
Tolmetin—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000523	0.00231	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00052	0.00563	CbGpPWpGaD
Tolmetin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000517	0.00228	CcSEcCtD
Tolmetin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000515	0.00227	CcSEcCtD
Tolmetin—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000515	0.00227	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000514	0.00556	CbGpPWpGaD
Tolmetin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000514	0.00227	CcSEcCtD
Tolmetin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000512	0.00226	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000511	0.00552	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.00051	0.00551	CbGpPWpGaD
Tolmetin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00051	0.00225	CcSEcCtD
Tolmetin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000509	0.00225	CcSEcCtD
Tolmetin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000507	0.00224	CcSEcCtD
Tolmetin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000506	0.00223	CcSEcCtD
Tolmetin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000505	0.00223	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000502	0.00543	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000501	0.00541	CbGpPWpGaD
Tolmetin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000495	0.00218	CcSEcCtD
Tolmetin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000494	0.00218	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.000493	0.00533	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000493	0.00533	CbGpPWpGaD
Tolmetin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000492	0.00217	CcSEcCtD
Tolmetin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000492	0.00217	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000492	0.00532	CbGpPWpGaD
Tolmetin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000491	0.00217	CcSEcCtD
Tolmetin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00049	0.00216	CcSEcCtD
Tolmetin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00049	0.00216	CcSEcCtD
Tolmetin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000486	0.00215	CcSEcCtD
Tolmetin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000486	0.00214	CcSEcCtD
Tolmetin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000484	0.00214	CcSEcCtD
Tolmetin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000483	0.00213	CcSEcCtD
Tolmetin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000481	0.00212	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000477	0.00516	CbGpPWpGaD
Tolmetin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000475	0.0021	CcSEcCtD
Tolmetin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000474	0.00209	CcSEcCtD
Tolmetin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000474	0.00209	CcSEcCtD
Tolmetin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000473	0.00209	CcSEcCtD
Tolmetin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000472	0.00208	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00047	0.00509	CbGpPWpGaD
Tolmetin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000468	0.00206	CcSEcCtD
Tolmetin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000467	0.00206	CcSEcCtD
Tolmetin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000466	0.00206	CcSEcCtD
Tolmetin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000465	0.00205	CcSEcCtD
Tolmetin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000465	0.00205	CcSEcCtD
Tolmetin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000464	0.00205	CcSEcCtD
Tolmetin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000461	0.00203	CcSEcCtD
Tolmetin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00046	0.00203	CcSEcCtD
Tolmetin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000458	0.00202	CcSEcCtD
Tolmetin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000458	0.00202	CcSEcCtD
Tolmetin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000457	0.00202	CcSEcCtD
Tolmetin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000456	0.00201	CcSEcCtD
Tolmetin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000455	0.00201	CcSEcCtD
Tolmetin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00045	0.00199	CcSEcCtD
Tolmetin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000449	0.00198	CcSEcCtD
Tolmetin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000449	0.00198	CcSEcCtD
Tolmetin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000448	0.00197	CcSEcCtD
Tolmetin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000447	0.00197	CcSEcCtD
Tolmetin—PTGS1—brain—acquired immunodeficiency syndrome	0.000447	0.00497	CbGeAlD
Tolmetin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000447	0.00197	CcSEcCtD
Tolmetin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000444	0.00196	CcSEcCtD
Tolmetin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000444	0.00196	CcSEcCtD
Tolmetin—PTGS1—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000444	0.0048	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000442	0.00478	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000442	0.00478	CbGpPWpGaD
Tolmetin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000442	0.00195	CcSEcCtD
Tolmetin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000441	0.00194	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000438	0.00474	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000435	0.00192	CcSEcCtD
Tolmetin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000434	0.00192	CcSEcCtD
Tolmetin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000432	0.00191	CcSEcCtD
Tolmetin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000432	0.00191	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000432	0.00467	CbGpPWpGaD
Tolmetin—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000432	0.00481	CbGeAlD
Tolmetin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00043	0.0019	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00043	0.00465	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000428	0.00189	CcSEcCtD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	0.000427	0.00462	CbGpPWpGaD
Tolmetin—PTGS2—brain—acquired immunodeficiency syndrome	0.000427	0.00475	CbGeAlD
Tolmetin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000427	0.00188	CcSEcCtD
Tolmetin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000426	0.00188	CcSEcCtD
Tolmetin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000426	0.00188	CcSEcCtD
Tolmetin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000425	0.00188	CcSEcCtD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	0.000422	0.00457	CbGpPWpGaD
Tolmetin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000419	0.00185	CcSEcCtD
Tolmetin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000416	0.00183	CcSEcCtD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	0.000416	0.00449	CbGpPWpGaD
Tolmetin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000415	0.00183	CcSEcCtD
Tolmetin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000414	0.00183	CcSEcCtD
Tolmetin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000414	0.00183	CcSEcCtD
Tolmetin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000414	0.00183	CcSEcCtD
Tolmetin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000414	0.00183	CcSEcCtD
Tolmetin—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000413	0.00459	CbGeAlD
Tolmetin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000412	0.00182	CcSEcCtD
Tolmetin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00041	0.00181	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000401	0.00433	CbGpPWpGaD
Tolmetin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000398	0.00176	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	0.000398	0.0043	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000398	0.0043	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000397	0.00429	CbGpPWpGaD
Tolmetin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000396	0.00175	CcSEcCtD
Tolmetin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000396	0.00175	CcSEcCtD
Tolmetin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000396	0.00175	CcSEcCtD
Tolmetin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000395	0.00174	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000393	0.00424	CbGpPWpGaD
Tolmetin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000392	0.00173	CcSEcCtD
Tolmetin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000391	0.00173	CcSEcCtD
Tolmetin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00039	0.00172	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	0.000389	0.00421	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000389	0.00421	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—acquired immunodeficiency syndrome	0.000388	0.0042	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	0.000386	0.00417	CbGpPWpGaD
Tolmetin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000384	0.0017	CcSEcCtD
Tolmetin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000383	0.00169	CcSEcCtD
Tolmetin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000383	0.00169	CcSEcCtD
Tolmetin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000383	0.00169	CcSEcCtD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—acquired immunodeficiency syndrome	0.000381	0.00412	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000381	0.00168	CcSEcCtD
Tolmetin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00038	0.00168	CcSEcCtD
Tolmetin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000375	0.00166	CcSEcCtD
Tolmetin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000374	0.00165	CcSEcCtD
Tolmetin—CXCL8—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000373	0.00404	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000373	0.00404	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	0.000371	0.00401	CbGpPWpGaD
Tolmetin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00037	0.00163	CcSEcCtD
Tolmetin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00037	0.00163	CcSEcCtD
Tolmetin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000368	0.00162	CcSEcCtD
Tolmetin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000368	0.00162	CcSEcCtD
Tolmetin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000368	0.00162	CcSEcCtD
Tolmetin—CXCL8—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000364	0.00394	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000363	0.0016	CcSEcCtD
Tolmetin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000363	0.0016	CcSEcCtD
Tolmetin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000362	0.0016	CcSEcCtD
Tolmetin—PTGS1—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000358	0.00388	CbGpPWpGaD
Tolmetin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000358	0.00158	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—IL2—acquired immunodeficiency syndrome	0.000353	0.00382	CbGpPWpGaD
Tolmetin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000353	0.00156	CcSEcCtD
Tolmetin—PTGS2—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000353	0.00381	CbGpPWpGaD
Tolmetin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000351	0.00155	CcSEcCtD
Tolmetin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000351	0.00155	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000349	0.00377	CbGpPWpGaD
Tolmetin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000348	0.00153	CcSEcCtD
Tolmetin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000347	0.00153	CcSEcCtD
Tolmetin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.00153	CcSEcCtD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—acquired immunodeficiency syndrome	0.000345	0.00373	CbGpPWpGaD
Tolmetin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000344	0.00152	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	0.000343	0.00371	CbGpPWpGaD
Tolmetin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000343	0.00151	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000337	0.00364	CbGpPWpGaD
Tolmetin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000334	0.00147	CcSEcCtD
Tolmetin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000333	0.00147	CcSEcCtD
Tolmetin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000331	0.00146	CcSEcCtD
Tolmetin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.00145	CcSEcCtD
Tolmetin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000325	0.00143	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000323	0.0035	CbGpPWpGaD
Tolmetin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.00141	CcSEcCtD
Tolmetin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000319	0.00141	CcSEcCtD
Tolmetin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000319	0.00141	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000318	0.00344	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IFNG—acquired immunodeficiency syndrome	0.000317	0.00343	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000316	0.00341	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000315	0.0034	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	0.000313	0.00338	CbGpPWpGaD
Tolmetin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000311	0.00137	CcSEcCtD
Tolmetin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.00136	CcSEcCtD
Tolmetin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.00136	CcSEcCtD
Tolmetin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.00134	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000303	0.00328	CbGpPWpGaD
Tolmetin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.00134	CcSEcCtD
Tolmetin—PTGS2—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000302	0.00326	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000297	0.00321	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000297	0.00321	CbGpPWpGaD
Tolmetin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000296	0.00131	CcSEcCtD
Tolmetin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.0013	CcSEcCtD
Tolmetin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.00129	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.000289	0.00312	CbGpPWpGaD
Tolmetin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00127	CcSEcCtD
Tolmetin—PTGS2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000285	0.00308	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000284	0.00307	CbGpPWpGaD
Tolmetin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.00125	CcSEcCtD
Tolmetin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000278	0.00123	CcSEcCtD
Tolmetin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000277	0.00122	CcSEcCtD
Tolmetin—CXCL8—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000266	0.00287	CbGpPWpGaD
Tolmetin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.00116	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000262	0.00284	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TNF—acquired immunodeficiency syndrome	0.000257	0.00278	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000257	0.00278	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000256	0.00277	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000256	0.00277	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.000251	0.00272	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000242	0.00261	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00024	0.0026	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000229	0.00247	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000226	0.00244	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000226	0.00244	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000226	0.00244	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000223	0.00241	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000221	0.00239	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000221	0.00239	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000215	0.00233	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.00021	0.00227	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000209	0.00226	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000203	0.0022	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	0.000202	0.00218	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000201	0.00218	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.0002	0.00216	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000192	0.00207	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.000187	0.00202	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000175	0.00189	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000174	0.00188	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000172	0.00186	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000169	0.00183	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—acquired immunodeficiency syndrome	0.000165	0.00179	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	0.000165	0.00179	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	0.000164	0.00177	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	0.000163	0.00176	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.00016	0.00173	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.00016	0.00173	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000155	0.00167	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	0.000151	0.00163	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000149	0.00162	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000136	0.00147	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000136	0.00147	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	0.000132	0.00143	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00013	0.00141	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00013	0.00141	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.00013	0.00141	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000128	0.00138	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000128	0.00138	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000127	0.00137	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.000126	0.00137	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000123	0.00133	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000121	0.0013	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000118	0.00128	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000116	0.00125	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000116	0.00125	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000115	0.00124	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000112	0.00121	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000108	0.00116	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000105	0.00114	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—acquired immunodeficiency syndrome	0.000105	0.00113	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000103	0.00112	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ALB—acquired immunodeficiency syndrome	0.000103	0.00111	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	0.0001	0.00109	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.71e-05	0.00105	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	9.59e-05	0.00104	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.57e-05	0.00103	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.82e-05	0.000954	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.75e-05	0.000946	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.69e-05	0.00094	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	8.54e-05	0.000924	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	8.35e-05	0.000903	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	8.18e-05	0.000885	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	8.16e-05	0.000882	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.06e-05	0.000871	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.95e-05	0.000859	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	7.91e-05	0.000856	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.29e-05	0.000788	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.85e-05	0.000741	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.85e-05	0.000741	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	6.6e-05	0.000714	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5.82e-05	0.00063	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	5.57e-05	0.000602	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.21e-05	0.000563	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.13e-05	0.000555	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.06e-05	0.000547	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	4.96e-05	0.000536	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.69e-05	0.000508	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.59e-05	0.000496	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	4.28e-05	0.000463	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.93e-05	0.000425	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	2.94e-05	0.000318	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.71e-05	0.000293	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.7e-05	0.000292	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	2.21e-05	0.000239	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	1.84e-05	0.000199	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	1.75e-05	0.000189	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.59e-05	0.000172	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	9.97e-06	0.000108	CbGpPWpGaD
